GENERAL ATLANTIC, L.P. → Seaport Therapeutics, Inc. (SPTX)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

25 filings by this filer

24 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by GENERAL ATLANTIC, L.P.

Filed	Form	Issuer	Stake	Shares
2026-05-15	SCHEDULE 13D/A	ALKAMI TECHNOLOGY, INC.	18.10%	19,420,994	view →
2025-02-13	SCHEDULE	Third Harmonic Bio, Inc.	—	—	view →
2025-01-22	SCHEDULE	Third Harmonic Bio, Inc.	8.00%	3,623,910	view →
2023-12-11	SC	Arco Platform Ltd.	—	—	view →
2023-08-14	SC	Arco Platform Ltd.	—	—	view →
2023-07-11	SC	XP Inc. XP	—	—	view →
2023-05-01	SC	Arco Platform Ltd.	—	—	view →
2023-04-25	SC	dLocal Ltd DLO	—	—	view →
2023-02-28	SC	CinCor Pharma, Inc.	—	—	view →
2023-01-17	SC	Immunocore Holdings plc IMCR	—	—	view →
2023-01-11	SC	Arco Platform Ltd.	—	—	view →
2023-01-11	SC	CinCor Pharma, Inc.	—	—	view →
2022-11-28	SC	China Index Holdings Ltd	—	—	view →
2021-07-01	SC	HUTCHMED (China) Ltd HMDCF	—	—	view →
2021-01-05	SC	Futu Holdings Ltd FUTU	—	—	view →
2020-11-30	SC	Fang Holdings Ltd SFUNY	—	—	view →
2020-11-25	SC	Futu Holdings Ltd FUTU	—	—	view →
2020-09-03	SC	Futu Holdings Ltd FUTU	—	—	view →
2020-06-22	SC	58.com Inc.	—	—	view →
2020-05-04	SC	58.com Inc.	—	—	view →

Showing 20 of 24

GENERAL ATLANTIC, L.P. → Seaport Therapeutics, Inc. SPTX

Item 4 — Purpose of Transaction

Cross-References

Other Filings by GENERAL ATLANTIC, L.P.

Want this depth on every filing the moment it hits SEC EDGAR?